National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 380750

History of Changes from the VAERS Wayback Machine

First Appeared on 3/2/2010

VAERS ID: 380750
Age:16.0
Gender:Female
Location:Foreign
Vaccinated:2008-09-08
Onset:2008-09-08
Submitted:2010-02-17
Entered:2010-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0583U / 1 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amenorrhoea, Asthenia, Decreased activity, Fatigue, Gait disturbance, Headache, Hyperhidrosis, Malaise, Muscular weakness, Myalgia, Bedridden, Abasia, Muscle fatigue, Activities of daily living impaired, Post viral fatigue syndrome

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1002USA01872

Write-up:Information was obtained on a request by the company from the agency via a Public Case Details form concerning a 16 year old female who on 08-SEP-2008 was vaccinated with a dose of GARDASIL (batch number J2896, lot number 657872/0583U). On 08-SEP-2008, after second dose of GARDASIL the patient experienced generalized muscular weakness, severe headache-could not participate in sports at school. The next 5-6 weeks the patient experienced severe and continual headaches, muscle pain and weakness to the extent that the patient had to be carried to the toilet and was bed-bound. The mother also reported that student did not menstruate at all in between her first and second dose of GARDASIL. The mother also commented that the student had noticed "that she was sweating a lot" between dose 1 and dose 2 of GARDASIL. On 03-JUN-2009 the patient was still unwell and was experiencing the same symptoms, (severe headaches, muscle fatigue, has difficulty walking due to weakness) and extreme fatigue. The patient had not been able to return to school as too unwell. The patient was hospitalized for 1 week under the care of immunologist who diagnosed the patient with "post viral fatigue". The patient had been referred to a clinic for ongoing reaction with a physiologist and psychologist. At the time of reporting on 21-SEP-2009, the patient had not recovered. The agency considered that muscular weakness, amenorrhoea, fatigue, headache and hyperhidrosis were possibly related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.


Changed on 8/31/2010

VAERS ID: 380750 Before After
Age:16.0
Gender:Female
Location:Foreign
Vaccinated:2008-09-08
Onset:2008-09-08
Submitted:2010-02-17
Entered:2010-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0583U / 1 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amenorrhoea, Asthenia, Decreased activity, Difficulty in walking, Fatigue, Gait disturbance, Headache, Hyperhidrosis, Malaise, Muscular weakness, Myalgia, Bedridden, Abasia, Muscle fatigue, Activities of daily living impaired, Post viral fatigue syndrome

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1002USA01872

Write-up:Information was obtained on a request by the company from the agency via a Public Case Details form concerning a 16 year old female who on 08-SEP-2008 was vaccinated with a dose of GARDASIL (batch number J2896, lot number 657872/0583U). On 08-SEP-2008, after second dose of GARDASIL the patient experienced generalized muscular weakness, severe headache-could not participate in sports at school. The next 5-6 weeks the patient experienced severe and continual headaches, muscle pain and weakness to the extent that the patient had to be carried to the toilet and was bed-bound. The mother also reported that student did not menstruate at all in between her first and second dose of GARDASIL. The mother also commented that the student had noticed "that she was sweating a lot" between dose 1 and dose 2 of GARDASIL. On 03-JUN-2009 the patient was still unwell and was experiencing the same symptoms, (severe headaches, muscle fatigue, has difficulty walking due to weakness) and extreme fatigue. The patient had not been able to return to school as too unwell. The patient was hospitalized for 1 week under the care of immunologist who diagnosed the patient with "post viral fatigue". The patient had been referred to a clinic for ongoing reaction with a physiologist and psychologist. At the time of reporting on 21-SEP-2009, the patient had not recovered. The agency considered that muscular weakness, amenorrhoea, fatigue, headache and hyperhidrosis were possibly related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.


Changed on 1/4/2011

VAERS ID: 380750 Before After
Age:16.0
Gender:Female
Location:Foreign
Vaccinated:2008-09-08
Onset:2008-09-08
Submitted:2010-02-17
Entered:2010-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0583U / 1 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amenorrhoea, Asthenia, Decreased activity, Difficulty in walking, Fatigue, Gait disturbance, Headache, Hyperhidrosis, Malaise, Muscular weakness, Myalgia, Bedridden, Abasia, Muscle fatigue, Activities of daily living impaired, Post viral fatigue syndrome

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1002USA01872

Write-up:Information was obtained on a request by the company from the agency via a Public Case Details form concerning a 16 year old female who on 08-SEP-2008 was vaccinated with a dose of GARDASIL (batch number J2896, lot number 657872/0583U). On 08-SEP-2008, after second dose of GARDASIL the patient experienced generalized muscular weakness, severe headache-could not participate in sports at school. The next 5-6 weeks the patient experienced severe and continual headaches, muscle pain and weakness to the extent that the patient had to be carried to the toilet and was bed-bound. The mother also reported that student did not menstruate at all in between her first and second dose of GARDASIL. The mother also commented that the student had noticed "that she was sweating a lot" between dose 1 and dose 2 of GARDASIL. On 03-JUN-2009 the patient was still unwell and was experiencing the same symptoms, (severe headaches, muscle fatigue, has difficulty walking due to weakness) and extreme fatigue. The patient had not been able to return to school as too unwell. The patient was hospitalized for 1 week under the care of immunologist who diagnosed the patient with "post viral fatigue". The patient had been referred to a clinic for ongoing reaction with a physiologist and psychologist. At the time of reporting on 21-SEP-2009, the patient had not recovered. The agency considered that muscular weakness, amenorrhoea, fatigue, headache and hyperhidrosis were possibly related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.


Changed on 6/14/2014

VAERS ID: 380750 Before After
Age:16.0
Gender:Female
Location:Foreign
Vaccinated:2008-09-08
Onset:2008-09-08
Submitted:2010-02-17
Entered:2010-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0583U / 1 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amenorrhoea, Asthenia, Decreased activity, Fatigue, Gait disturbance, Headache, Hyperhidrosis, Malaise, Muscular weakness, Myalgia, Bedridden, Abasia, Muscle fatigue, Activities of daily living impaired, Post viral fatigue syndrome

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1002USA01872

Write-up:Information was obtained on a request by the company from the agency via a Public Case Details form concerning a 16 year old female who on 08-SEP-2008 was vaccinated with a dose of GARDASIL (batch number J2896, lot number 657872/0583U). On 08-SEP-2008, after second dose of GARDASIL the patient experienced generalized muscular weakness, severe headache-could not participate in sports at school. The next 5-6 weeks the patient experienced severe and continual headaches, muscle pain and weakness to the extent that the patient had to be carried to the toilet and was bed-bound. The mother also reported that student did not menstruate at all in between her first and second dose of GARDASIL. The mother also commented that the student had noticed "that she was sweating a lot" between dose 1 and dose 2 of GARDASIL. On 03-JUN-2009 the patient was still unwell and was experiencing the same symptoms, (severe headaches, muscle fatigue, has difficulty walking due to weakness) and extreme fatigue. The patient had not been able to return to school as too unwell. The patient was hospitalized for 1 week under the care of immunologist who diagnosed the patient with "post viral fatigue". The patient had been referred to a clinic for ongoing reaction with a physiologist and psychologist. At the time of reporting on 21-SEP-2009, the patient had not recovered. The agency considered that muscular weakness, amenorrhoea, fatigue, headache and hyperhidrosis were possibly related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.


Changed on 4/14/2017

VAERS ID: 380750 Before After
Age:16.0
Gender:Female
Location:Foreign
Vaccinated:2008-09-08
Onset:2008-09-08
Submitted:2010-02-17
Entered:2010-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0583U / 1 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amenorrhoea, Asthenia, Decreased activity, Fatigue, Gait disturbance, Headache, Hyperhidrosis, Malaise, Muscular weakness, Myalgia, Bedridden, Abasia, Muscle fatigue, Activities of daily living impaired, Post viral fatigue syndrome

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1002USA01872

Write-up:Information was obtained on a request by the company from the agency via a Public Case Details form concerning a 16 year old female who on 08-SEP-2008 was vaccinated with a dose of GARDASIL (batch number J2896, lot number 657872/0583U). On 08-SEP-2008, after second dose of GARDASIL the patient experienced generalized muscular weakness, severe headache-could not participate in sports at school. The next 5-6 weeks the patient experienced severe and continual headaches, muscle pain and weakness to the extent that the patient had to be carried to the toilet and was bed-bound. The mother also reported that student did not menstruate at all in between her first and second dose of GARDASIL. The mother also commented that the student had noticed "that she was sweating a lot" between dose 1 and dose 2 of GARDASIL. On 03-JUN-2009 the patient was still unwell and was experiencing the same symptoms, (severe headaches, muscle fatigue, has difficulty walking due to weakness) and extreme fatigue. The patient had not been able to return to school as too unwell. The patient was hospitalized for 1 week under the care of immunologist who diagnosed the patient with "post viral fatigue". The patient had been referred to a clinic for ongoing reaction with a physiologist and psychologist. At the time of reporting on 21-SEP-2009, the patient had not recovered. The agency considered that muscular weakness, amenorrhoea, fatigue, headache and hyperhidrosis were possibly related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=380750&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166